Literature DB >> 17640869

Translation elongation factor eEF1A2 is essential for post-weaning survival in mice.

H J Newbery1, D H Loh, J E O'Donoghue, V A L Tomlinson, Y-Y Chau, J A Boyd, J H Bergmann, D Brownstein, C M Abbott.   

Abstract

Translation elongation factor eEF1A, formerly known as EF-1 alpha, exists as two variant forms; eEF1A1, which is almost ubiquitously expressed, and eEF1A2, whose expression is restricted to muscle and brain at the level of whole tissues. Expression analysis of these genes has been complicated by a general lack of availability of antibodies that specifically recognize each variant form. Wasted mice (wst/wst) have a 15.8-kilobase deletion that abolishes activity of eEF1A2, but before this study it was unknown whether the deletion also affected neighboring genes. We have generated a panel of anti-peptide antibodies and used them to show that eEF1A2 is expressed at high levels in specific cell types in tissues previously thought not to express this variant, such as pancreatic islet cells and enteroendocrine cells in colon crypts. Expression of eEF1A1 and eEF1A2 is shown to be generally mutually exclusive, and we relate the expression pattern of eEF1A2 to the phenotype seen in wasted mice. We then carried out a series of transgenic experiments to establish whether the expression of other genes is affected by the deletion in wasted mice. We show that aspects of the phenotype such as motor neuron degeneration relate precisely to the relative expression of eEF1A1 and eEF1A2, whereas the immune system abnormalities are likely to result from a stress response. We conclude that loss of eEF1A2 function is solely responsible for the abnormalities seen in these mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640869     DOI: 10.1074/jbc.M703962200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser⁵³ is a novel substrate for protein kinase C βI.

Authors:  Manuela Piazzi; Alberto Bavelloni; Irene Faenza; William Blalock; Andrea Urbani; Simona D'Aguanno; Roberta Fiume; Giulia Ramazzotti; Nadir Mario Maraldi; Lucio Cocco
Journal:  Mol Cell Proteomics       Date:  2010-10-05       Impact factor: 5.911

2.  Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death.

Authors:  Siqi Cao; Laura L Smith; Sergio R Padilla-Lopez; Brandon S Guida; Elizabeth Blume; Jiahai Shi; Sarah U Morton; Catherine A Brownstein; Alan H Beggs; Michael C Kruer; Pankaj B Agrawal
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

3.  Generation of a cholangiocyte-specific cDNA expression library for the identification of B and T cell autoantigens in murine biliary disease.

Authors:  Rebecca M Tucker; Cara L Mack
Journal:  Hepatol Res       Date:  2012-01-11       Impact factor: 4.288

4.  Analysis of the Expression and Subcellular Distribution of eEF1A1 and eEF1A2 mRNAs during Neurodevelopment.

Authors:  Zoe Wefers; Celia Alecki; Ryan Huang; Suleima Jacob-Tomas; Maria Vera
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

5.  Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B.

Authors:  Pedro A Sánchez-Murcia; Álvaro Cortés-Cabrera; Federico Gago
Journal:  J Comput Aided Mol Des       Date:  2017-09-12       Impact factor: 3.686

6.  Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology.

Authors:  Lyndsay M Murray; Derek Thomson; Annalijn Conklin; Thomas M Wishart; Thomas H Gillingwater
Journal:  J Anat       Date:  2008-12       Impact factor: 2.610

7.  Damaging de novo missense variants in EEF1A2 lead to a developmental and degenerative epileptic-dyskinetic encephalopathy.

Authors:  Gemma L Carvill; Katherine L Helbig; Candace T Myers; Marcello Scala; Robert Huether; Sara Lewis; Tyler N Kruer; Brandon S Guida; Somayeh Bakhtiari; Joy Sebe; Sha Tang; Heather Stickney; Sehribani Ulusoy Oktay; Ashwin A Bhandiwad; Keri Ramsey; Vinodh Narayanan; Timothy Feyma; Luis O Rohena; Andrea Accogli; Mariasavina Severino; Georgina Hollingsworth; Deepak Gill; Christel Depienne; Caroline Nava; Lynette G Sadleir; Paul A Caruso; Angela E Lin; Floor E Jansen; Bobby Koeleman; Eva Brilstra; Marjolein H Willemsen; Tjitske Kleefstra; Joaquim Sa; Marie-Laure Mathieu; Laurine Perrin; Gaetan Lesca; Pasquale Striano; Giorgio Casari; Ingrid E Scheffer; David Raible; Evelyn Sattlegger; Valeria Capra; Sergio Padilla-Lopez; Heather C Mefford; Michael C Kruer
Journal:  Hum Mutat       Date:  2020-04-06       Impact factor: 4.878

Review 8.  Regulation of mRNA Translation in Neurons-A Matter of Life and Death.

Authors:  Mridu Kapur; Caitlin E Monaghan; Susan L Ackerman
Journal:  Neuron       Date:  2017-11-01       Impact factor: 17.173

9.  Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells.

Authors:  C Sanges; C Scheuermann; R P Zahedi; A Sickmann; A Lamberti; N Migliaccio; A Baljuls; M Marra; S Zappavigna; J Reinders; U Rapp; A Abbruzzese; M Caraglia; P Arcari
Journal:  Cell Death Dis       Date:  2012-03-01       Impact factor: 8.469

10.  Haploinsufficiency for translation elongation factor eEF1A2 in aged mouse muscle and neurons is compatible with normal function.

Authors:  Lowri A Griffiths; Jennifer Doig; Antonia M D Churchhouse; Faith C J Davies; Charlotte E Squires; Helen J Newbery; Catherine M Abbott
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.